Tissue Science Laboratories targets wider application of technology for the US
This article was originally published in Clinica
Executive Summary
UK company Tissue Science Laboratories (TSL), which specialises in human tissue replacement and repair, plans to use the £12 million ($17 million) proceeds from its flotation next month for commercial expansion for its products in the US.